Search for: "Myriad Genetics"
Results 241 - 260
of 856
Sorted by Relevance
|
Sort by Date
3 Nov 2009, 3:40 pm
Perhaps you have heard, the ALCU is standing up for breast cancer patients because Myriad Genetics has patented genes. [read post]
31 Oct 2013, 9:27 pm
Noonan -- Some of our commenters have asked (with greater or lesser degrees of stridency) that we "take a position" on claims like the Myriad method claims at issue in the lawsuits brought against Ambry Genetics, Gene-by-Gene, and Quest (and purportedly threatened against others). [read post]
12 Feb 2013, 9:59 pm
Myriad Genetics, Inc., the United States asks the Supreme Court to affirm the judgment of the Federal Circuit that cDNA is patent-eligible and reverse the judgment of the appellate court that isolated but otherwise unmodified DNA is patent-eligible. [read post]
20 Jun 2013, 12:21 pm
The court struck down arguments made by Myriad Genetics, which argued that it spent millions of dollars isolating these genes, which should be eligible for patent protection. [read post]
18 Oct 2015, 12:24 am
Myriad Genetics, Inc, which the US Office treated as affecting the patent-eligibility of all claims directed or relating to natural products. [read post]
17 Jun 2010, 10:42 am
The ACLU and the Public Patent Foundation filed a groundbreaking lawsuit against the United States Patent and Trademark Office and Myriad Genetics charging that Myriad's patents on two human genes associated with hereditary breast and ovarian cancer (BRCA1 and BRCA2) are invalid. [read post]
12 Dec 2011, 1:37 pm
Yet, as I argue in Standing to Sue in the Myriad Genetics Case, 2 Cal. [read post]
26 Jul 2014, 9:14 pm
Myriad Genetics, Inc, while a corresponding Australian patent came before the Australian Federal Court in Cancer Voices Australia v Myriad Genetics Inc (see Australian Federal Court Declares Isolated Human Genes Patentable). [read post]
16 Jun 2013, 9:22 pm
Myriad Genetics, Inc., No. 12-398, slip op. 12 (U.S. [read post]
6 Mar 2013, 4:49 pm
Myriad Genetics Inc. et al., was filed on March 4, 2013 to a Full Bench of the Federal Court of Australia by the law firm of Maurice Blackburn on behalf of cancer survivor Yvonne D’Arcy. [read post]
10 Jan 2010, 7:58 am
The gist of the Los Angeles Times editorial is that the position of Myriad should be opposed on POLICY grounds:The public clearly benefits from the investments that private companies make in genetic research. [read post]
3 Nov 2010, 12:33 pm
The issue is that Myriad is charging high prices, which could possibly keep some women from seeking preventative genetic testing. [read post]
14 Jun 2013, 2:08 pm
Myriad’s claims are simply not expressed in terms of chemical composition….Instead, the claims understandably focus on the genetic information encoded in the BRCA1 and BRCA2 genes…[Myriad’s] claim is concerned primarily with the information contained in the genetic sequence, not with the specific chemical composition of a particular molecule. [read post]
9 May 2013, 9:22 am
Myriad Genetics is whether the BRCA patents are good for innovation and ultimately for patients. [read post]
25 Aug 2011, 4:52 am
AND In 2006, Professor King and colleagues published a paper showing that Myriad’s test, known as the Comprehensive BRACAnalysis, actually failed to detect a significant number of genetic alterations in the two genes. [read post]
2 Nov 2009, 5:56 pm
The only trouble is that this is not what the US Patent Office allows, and it is not what Myriad Genetics has been granted a patent on. [read post]
18 Feb 2019, 5:33 pm
Keywords: Human Genes, Genetic Patenting, Research Stagnation, Commercial Interest, Patent Laws, Sense of Property, Morality, Ethics and Order, Knowledge, Innovative Technology, Universality of Rules, Legal Framework, Gene Therapy Preferred Citation Anjana Satheesh & Gauri S, Human genetic research and patenting: an overview, The LexWarrier: Online Law Journal (2019) 2, pp. 92 – 107, ISSN (O): 2319-8338 Read the full paper The post Human genetic research and… [read post]
9 Nov 2010, 9:59 pm
USPTO (the Myriad case). [read post]
31 Jul 2011, 7:59 pm
Myriad Genetics, No. 2010-1426 (Fed. [read post]
8 Oct 2015, 9:14 pm
In particular, all seven High Court judges found that claims 1-3 of Myriad Genetics’ Australian patent no. 686004, each of which is directed to isolated nucleic acid molecules corresponding with the BRCA mutation associated with increased breast cancer risk, are invalid because they do not define a patent-eligible ‘manner of manufacture’ under Australian law: D'Arcy v Myriad Genetics Inc [2015] HCA 35.In arriving at this ruling, the… [read post]
